Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

April 19, 2021 1:17 pm Published by

Cohen YC, Zada M, Wang S-Y, Bornstein C, David E, Moshe A, Li B, Shlomi-Loubaton S, Gatt ME, Gur C, Lavi N, Ganzel C, Luttwak E, Chubar E, Rouvio O, Vaxman I, Pasvolsky O, Ballan M, Tadmor T, Nemets A, Jarchowcky-Dolberg O, Shvetz O, Laiba M, Shpilberg O, Dally N, Avivi I, Weiner A & Amit I: Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nature Medicine 27, 491–503 (2021).

Categorised in:

This post was written by redakteur